Mersana Therapeutics announces $27 milion in private placement
12:41 EDT 1 Aug 2012 | Current Partnering
Mersana Therapeutics has closed a $27 million Series A-1 financing led by new investor New Enterprise Associates . Participation in the round also included new investor Pfizer Venture Investments and existing investors Fidelity Biosciences, ProQuest Investments, Rho Ventures and Harris and Harris Group. The proceeds from this financing will be used to advance Mersana’s Fleximer-based [...]The post Mersana Therapeutics announces $27 milion in private placement appeared first on Current Part..
Original Article: Mersana Therapeutics announces $27 milion in private placement
More From BioPortfolio on "Mersana Therapeutics announces $27 milion in private placement"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
